§ BIOTECHNOLOGY
USD · Biotechnology

FOLD

AMICUS THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.48
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
0 increased/new, 1 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B16.06EPS (TTM)-0.09
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.33.9M0.0%+4%
UBS Group AG16.0M0.0%+171%
VANGUARD CAPITAL MANAGEMENT LLC14.0Mn/an/a
Pentwater Capital Management LP14.0M1.0%+22%
VANGUARD PORTFOLIO MANAGEMENT LLC14.0Mn/an/a
State Street12.9M0.0%−13%
◇ AC INTELLIGENCE

Top institutional owners for FOLD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER55.2% · 208 holders
DEALER / BANK22.6% · 28 holders
PASSIVE / INDEX14.8% · 9 holders
QUALITY / COMPOUNDER8.7% · 19 holders
TACTICAL / MACRO6.0% · 6 holders
INCOME / DEFENSIVE1.8% · 16 holders
SYSTEMATIC / QUANT1.5% · 9 holders
DEEP VALUE0.3% · 1 holder
ACTIVIST0.2% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for FOLD in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES